Centre for Global Public Health, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Ashodaya Samithi, Mysuru, India.
Glob Public Health. 2020 Jun;15(6):889-904. doi: 10.1080/17441692.2020.1724316. Epub 2020 Feb 18.
To inform PrEP roll out, Ashodaya Samithi, a sex workers' collective, conducted a community-led prospective demonstration project among female sex workers in Mysore and Mandya, India. Following a community preparedness phase and pre-screening, participants were recruited for clinical screening and enrolment, provided PrEP as part of combination HIV prevention, and followed for 16 months. Adherence was measured by self-reported pill intake and by tenofovir blood level testing among a subset of participants. Of the 647 participants enrolled, 640 completed follow-up. Condom use remained stable and no HIV seroconversions occurred. Self-reported daily PrEP intake over the last month was 97.97% at the end of the study. Tenofovir blood levels >40 ng/mL (consistent with steady state dosing) were detected among 80% ( = 68/85) and 90.48% ( = 76/84) of participants at month 3 and 6, respectively. Our study holds important insights for rolling out PrEP in community settings as part of targeted HIV prevention interventions.
为了推动 PrEP 的推广,Ashodaya Samithi(一个性工作者团体)在印度迈索尔和芒迪亚的女性性工作者中开展了一项社区主导的前瞻性示范项目。在社区准备阶段和预筛查之后,参与者被招募进行临床筛查和入组,作为 HIV 综合预防的一部分提供 PrEP,并随访 16 个月。通过自我报告的药物摄入和对一部分参与者的替诺福韦血液水平检测来衡量依从性。在 647 名入组的参与者中,有 640 名完成了随访。 condom 使用保持稳定,没有 HIV 血清转换发生。在研究结束时,最后一个月自我报告的每日 PrEP 摄入率为 97.97%。在第 3 个月和第 6 个月,分别有 80%(=68/85)和 90.48%(=76/84)的参与者检测到替诺福韦血液水平>40ng/mL(与稳定剂量一致)。我们的研究为在社区环境中作为有针对性的 HIV 预防干预措施的一部分推出 PrEP 提供了重要的见解。